Seroatlas · Human Serome Atlas

FHIP2A

FHF complex subunit HOOK interacting protein 2A

Also known as: bA106M7.3, FAM160B1, FHI2A_HUMAN, KIAA1600

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q5W0V3
Gene
FHIP2A
Ensembl
ENSG00000151553
Chromosome
10
Canonical length
765 aa
Protein class
Predicted intracellular proteins
Subcellular location
Nuclear speckles,Cytosol

OverviewNCBI Gene

No narrative summary is available for FHIP2A in this catalog release; identity and structured annotations are shown without generated factual claims.

Canonical amino-acid sequenceUniProt

765 residues, UniProt reviewed canonical sequence.

>Q5W0V3|FHIP2A
     1  MFSKFTSILQ HAVEALAPSL PLQEDFVYHW KAITHYYIET SDDKAPVTDT NIPSHLEQML
    61  DILVQEENER ESGETGPCME YLLHHKILET LYTLGKADCP PGMKQQVLVF YTKLLGRIRQ
   121  PLLPHINVHR PVQKLIRLCG EVLATPTENE EIQFLCIVCA KLKQDPYLVN FFLENKMKSL
   181  ASKGVPNVIS EDTLKGQDSL STDTGQSRQP EELSGATGME QTELEDEPPH QMDHLSTSLD
   241  NLSVTSLPEA SVVCPNQDYN LVNSLLNLTR SPDGRIAVKA CEGLMLLVSL PEPAAAKCLT
   301  QSTCLCELLT DRLASLYKAL PQSVDPLDIE TVEAINWGLD SYSHKEDASA FPGKRALISF
   361  LSWFDYCDQL IKEAQKTAAV ALAKAVHERF FIGVMEPQLM QTSEMGILTS TALLHRIVRQ
   421  VTSDVLLQEM VFFILGEQRE PETLAEISRH PLRHRLIEHC DHISDEISIM TLRMFEHLLQ
   481  KPNEHILYNL VLRNLEERNY TEYKPLCPED KDVVENGLIA GAVDLEEDPL FTDISPENTL
   541  PNQEWLSSSP PATPDHPKND GKTEVHKIVN SFLCLVPDDA KSSYHVEGTG YDTYLRDAHR
   601  QFRDYCAICL RWEWPGSPKA LEKCNLEAAF FEGHFLKVLF DRMGRILDQP YDVNLQVTSV
   661  LSRLSLFPHP HIHEYLLDPY VNLAPGCRSL FSVIVRVVGD LMLRIQRIQD FTPKLLLVRK
   721  RLLGLEPEGP IIDHITLLEG VIVLEEFCKE LAAIAFVKYH ASSTP

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against FHIP2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Unknown
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.33
Highest tissue expression
50 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 50 nTPM
  • skeletal muscle: 20 nTPM
  • liver: 18 nTPM
  • testis: 18 nTPM
  • smooth muscle: 16 nTPM
  • endometrium: 15 nTPM

Single-cell type

  • neutrophils: 161 nCPM
  • neutrophil progenitors: 142 nCPM
  • adrenal cortex cells: 81 nCPM
  • myonuclei: 79 nCPM
  • adipocytes: 72 nCPM
  • alveolar cells type 1: 69 nCPM

Immune cell

  • basophil: 20 nTPM
  • neutrophil: 15 nTPM
  • T-reg: 11 nTPM
  • memory CD8 T-cell: 9.2 nTPM
  • memory CD4 T-cell: 7.4 nTPM
  • naive CD8 T-cell: 5.5 nTPM

Brain region

  • amygdala: 33 nTPM
  • basal ganglia: 32 nTPM
  • cerebral cortex: 31 nTPM
  • hippocampal formation: 29 nTPM
  • thalamus: 29 nTPM
  • midbrain: 29 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about FHIP2A.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 88 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.25
gnomAD pLI
1
DepMap mean gene effect
0.05
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

Protein domainsUniProt · Pfam · InterPro

InteractionsUniProt · HPA

Protein binding partners of FHIP2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads FHIP2A as an antibody target. Whether an autoantibody or antibody against FHIP2A could matter depends on whether native FHIP2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

FHIP2A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label FHIP2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/FHIP2A. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...